The Securities and Exchange Commission has not necessarily
reviewed the information in this filing and has not determined
if it is accurate and complete.
| |||||||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| BIOAGE LABS INC | COM | 09077V100 | 8,777,059 | 501,833 | SH | SOLE | 501,833 | 0 | 0 | ||
| FIGMA INC | CLASS A COM STK | 316841105 | 85,722,446 | 4,054,988 | SH | SOLE | 4,054,988 | 0 | 0 | ||
| NAVAN INC | CL A | 639193101 | 94,517,302 | 7,138,769 | SH | SOLE | 7,138,769 | 0 | 0 | ||
| SAMSARA INC | COM CL A | 79589L106 | 39,800,865 | 1,255,944 | SH | SOLE | 1,255,944 | 0 | 0 | ||